“Pharmaceutical Glass Packaging Market Over USD 20.1 billion in 2020”, says Visiongain report

24 January 2020
Pharma

Visiongain’s new report the Pharmaceutical Glass Packaging Market Report 2020-2030: Forecasts by Product (Vials, Bottles, Cartridges & Syringes, Ampoules) plus analysis of leading companies indicates that the global Pharmaceutical Glass Packaging market will grow at a CAGR over 6% by 2030.

It is anticipated that high demand from the pharmaceutical industry and widespread use of generic injectable drugs would drive growth. Glass prohibits the entry into the primary tank of atmospheric gases such as oxygen and carbon dioxide, thereby eliminating pharmaceutical pollution. It also avoids potential degradation of the drug, such as oxidation and hydrolysis. Therefore, glass packaging improves the durability of the drug by preventing volatile ingredient escape. All of these factors are expected to increase the demand for the product in the near future. The new and improved products are made using glass chemistry and ion-exchange processes which resulted in the reduction of the surface friction coefficient and the inherent production of strong and damage-resistant glass. During the forecast period, this trend is expected to drive demand for pharmaceutical glass packaging products. Due to the high inertia of these products for most chemicals, the demand for glass vials is expected to remain high over the forecast period. In fact, the vials prohibit entry into the tank of atmospheric gases such as oxygen and carbon dioxide.

The vials, including oxidation and hydrolysis, also stop possible degradation. The vials stop the substance from escape into the environment through unstable ingredients and thus keep the drug / product safe. By addition, both glass and plastic are recyclable. The latter has its own set of drawbacks, though, as it can only be recycled back into glass. As a result, plastic loses its quality, as various items such as plastic lumber, carpet filling, and foam packaging among others can be reused, thereby restricting the growth of the industry.

Due to the large number of regional and global players, the market for pharmaceutical glass packaging is highly fragmented. The top ten players from the industry combined, however, accounted for most of the revenue in 2018. Because of the presence of a well-established pharmaceutical industry in these countries, a large number of manufacturers are mainly concentrated in developed regions, such as North America and Europe.

Growing importance of biotech drugs and cost-sensitivity in the healthcare sector has resulted in the establishment of stringent drug delivery products regulations. Most manufacturers of glass pharmaceutical packaging invest in products that aim to increase the drug's shelf-life, which is expected to increase demand in the coming years. Over the past couple of years, the global market for generic drugs has seen an increase due to the increase in pharmaceutical patent expiration, the aging population, and the increase in the prevalence of chronic diseases. Because of its superior barrier properties and regulatory ease, generics growth is expected to fuel demand for glass packaging.

The U.S. market is expected to remain a key area for various pharmaceutical glass packaging business activities. This is due to the significant rise in the country's amount of generics that is expected to undergo a rapid change in market dynamics mainly due to increased competitive intensity and consolidation of customers. Both combined instances put pressure on demand that is supposed to restrict branded product sales through patent expiries and low-cost generics.

Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@visiongain.com or call her on +44 (0) 207 336 6100.

About Visiongain
Visiongain is one of the fastest growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.

Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.

Recent News

“Global Cell Therapy Technologies market set to grow to $23bn by 2024” says new Visiongain report

Cell therapy technologies are used across various research areas including gene therapy, cancer vaccines, regenerative medicine, biologics and others. Increasing global disease burdens and the need for more personalised & precision medicine has led to massive growth in the cell technology market, which is likely to increase over the next decade.

19 February 2020

Read

“Global Asthma & COPD market set to grow to $49 bn by 2025” says new Visiongain report

The Asthma and COPD market has the potential to bring several blockbuster drugs to the marketplace due to the increasingly segmented sub-groups of patients.

17 February 2020

Read

“Global Rheumatoid Arthritis Drugs market estimated to grow at a CAGR of 0.6% in the second half of the forecast period” says Visiongain report

Another factor driving the growth in the market is the discovery of new molecules that are involved in the disease process, and hence, new strategies for treating the disease.

17 February 2020

Read

Visiongain assesses that the Contract Research Organisations (CROs) market will generate revenues of $38.0 billion in 2020

Global clinical research organizations market was valued at $34.9 billion in 2019 and is projected to grow at a CAGR of 9.5% during the forecast period 2020-2030.

12 February 2020

Read

Kelloggs
3m
Thales
Shell
TEVA
Lockheed-Martin
Pfizer
Raytheon
Halliburton
Du-Pont
Honeywell
Daimler
BASF
Bayer
BP
BAE-Systems
Unilever